Stock Groups

IDEXX Labs Earnings, Revenue Beat in Q4 -Breaking

by Mike Robinson

[ad_1]

© Reuters. IDEXX Labs Beats Q4 Revenue and Earnings

Investing.com — IDEXX Labs NASDAQ (NASDAQ:), reported that Wednesday’s fourth quarter saw revenue exceeding analysts’ expectations and beat forecasts.

IDEXX Labs posted earnings per share (EPS) of $1.83 on revenues of $801.09M. Investing.com polled analyst to predict EPS of $1.72 based on $781.83M in revenue.

IDEXX Labs shares rose 3% over the first of the year. However, they are down 27.32% from their 52 week high of $706.51 on August 4, 2021. They are outperforming the S&P 500 which is down 4.61% from the start of the year.

IDEXX Labs is following other important earnings from the Healthcare sector this month

IDEXX Labs’s report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.

UnitedHealth exceeded expectations by beating forecasts on January 19, posting fourth quarter EPS at $4.48 on revenues of $73.74B. This compares to the $4.3-$72.98B expected for.

You can keep up to date on the latest earnings reports at www.investors.com Investing.com’s earnings calendar

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]